A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. O'Connor PW, Li D, Freedman MS, Bar-Or A, Rice GPA, Confavreux C, Paty DW, Stewart JA, Scheyer R, Teriflunomide Multiple Sclerosis Trial Group, et al. Neurology. 2006 Mar 28; 66(6):894-900. PMID: 16567708. Abstract CommentRecommendBookmarkWatch